NUVOLI, Susanna Maria Francesca
 Distribuzione geografica
Continente #
NA - Nord America 8.203
EU - Europa 5.102
AS - Asia 2.580
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 30
SA - Sud America 24
AF - Africa 10
Totale 15.986
Nazione #
US - Stati Uniti d'America 8.163
UA - Ucraina 2.005
CN - Cina 1.793
SE - Svezia 1.006
DE - Germania 749
IT - Italia 534
SG - Singapore 506
FI - Finlandia 297
GB - Regno Unito 183
FR - Francia 136
HK - Hong Kong 110
KR - Corea 55
CZ - Repubblica Ceca 48
BE - Belgio 37
IN - India 36
CA - Canada 34
TR - Turchia 33
AU - Australia 31
EU - Europa 29
RO - Romania 20
BR - Brasile 16
PL - Polonia 13
JP - Giappone 11
NL - Olanda 11
IL - Israele 10
ES - Italia 9
IE - Irlanda 8
AT - Austria 7
IR - Iran 6
NZ - Nuova Zelanda 6
BG - Bulgaria 5
DK - Danimarca 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CH - Svizzera 3
CL - Cile 3
ID - Indonesia 3
LU - Lussemburgo 3
MX - Messico 3
RS - Serbia 3
BN - Brunei Darussalam 2
CR - Costa Rica 2
EG - Egitto 2
HU - Ungheria 2
IM - Isola di Man 2
MA - Marocco 2
MD - Moldavia 2
PE - Perù 2
RU - Federazione Russa 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CO - Colombia 1
FK - Isole Falkland (Malvinas) 1
GL - Groenlandia 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 15.986
Città #
Chandler 2.105
Jacksonville 1.290
Princeton 689
Dearborn 664
Nanjing 583
Singapore 369
Wilmington 287
Boardman 276
New York 274
Sassari 237
Nanchang 226
Beijing 171
Shenyang 142
Ann Arbor 114
Hong Kong 102
Woodbridge 98
Hebei 91
Jiaxing 90
Tianjin 90
Santa Clara 68
Changsha 67
Ashburn 63
Seoul 55
Munich 52
Kunming 46
Hangzhou 43
Brno 41
Norwalk 40
Brussels 37
San Francisco 37
Dallas 36
Jinan 36
Cagliari 28
Zhengzhou 26
Toronto 25
Helsinki 24
Ningbo 23
Alghero 22
Los Angeles 21
Izmir 20
Lanzhou 19
Guangzhou 18
Andover 17
Glasgow 16
West Jordan 16
Auburn Hills 15
Taizhou 15
Edinburgh 14
Leawood 14
Rome 14
Milan 13
Changchun 12
Falls Church 11
Melbourne 11
Shanghai 11
Warsaw 11
Chicago 10
Hefei 10
London 10
Seattle 10
Agrigento 9
Canberra 9
Stockholm 9
Horia 8
Selargius 8
Tokyo 8
Amsterdam 7
Augusta 7
Olomouc 7
Vienna 7
Città Di Castello 6
Haikou 6
Salerno 6
San Mateo 6
Sydney 6
Dublin 5
Frankfurt am Main 5
Fuzhou 5
São Paulo 5
Tel Aviv 5
Ardabil 4
Copenhagen 4
Cormeilles-en-Parisis 4
Dorgali 4
Hanover 4
Houston 4
Istanbul 4
Madrid 4
Markham 4
Mountain View 4
Sofia 4
Torino 4
Azzano San Paolo 3
Belgrade 3
Berlin 3
Birmingham 3
Dubai 3
Eindhoven 3
Jinhua 3
Minsk 3
Totale 9.181
Nome #
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 113
99mTc-Tetrofosmin Pinhole-SPECT (P-SPECT) and Radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging 90
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 90
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 87
123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders 72
99mTc HM-PAO Brain Spect Qualitative and Quantitative Analyses (QLA/QNA) In Fibromyalgia Syndrome (FMS) Treated With Hyperbaric Oxigen Therapy (HOT) 70
99mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis 70
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage 69
Plasma levels of leptin in heavy obese subjects 67
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). 67
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. 67
The role of Tc-99m Tetrofosmin (T) SPECT in mediastinal lymph node metastasis detection in lung cancer (LC). A.Spanu, F.Ginesu, A.Farris, M.E.Solinas, G.Deiola, C.Bagella, P.Pirina, G.C.Ginesu, S.Nuvoli, P.Solinas and G.Madeddu. Eur J Nucl Med 1997 66
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. 66
99mTc-Tetrofosmin scan in non small cell lung cancer (NSCLC) 66
Preoperative identification of residual breast tumor following neoadjuvant therapy: a breast-specific γ-camera (BSGC) planar scintigraphy and SPECT/CT comparative study. 66
Brain 18F-FDG PET qualitative and quantitative analyses in Atypical Parkinsonian Syndromes (APS) with Cognitive Clinical Symptoms (CCS) 65
The value of preoperative molecular breast imaging for the size assessment of invasive carcinoma and ductal carcinoma in situ 65
Central nervous system involvement in systemic lupus erythematosus patients as revealed by brain MRI and SPECT. M.Piga, L.Satta, G. Sanna, G.L.Loi, M.Floris, A.Vacca, M.Laudadio, A.Careddu, C.Montaldo, A.Spanu, S.Nuvoli, G.Madeddu, A.Mathieu. Q J Nucl Med 1996, 40 (suppl 1): 18 65
β-Endorphin and Cortisol Levels in Plasma and CSF Following Acute Experimental Spinal Traumas 64
Iodine-123 Ioflupano brain SPECT in extra-pyramidal movement disorders of recent appearance 64
The role of Tc-99m Tetrofosmin (T) SPECT in primary lung cancer detection 64
Breast scintigraphy with a breast specific gamma camera (BSGC) and dynamic breast magnetic resonance imaging (MRI) in the detection of primary breast cancer (BC): A comparative study 64
The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy 64
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 64
The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging 63
Alzheimer disease (AD) and Lewy bodies dementia (LBD) differential diagnosis: a 123Ioflupane SPECT study. 63
The usefulness of SPECT scintimammography in multifocal/multicentric breast cancer detection 63
Tc 99m-Tetrofosmin scan in lung and breast cancer detection 63
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. 63
131I-SPECT/CT in differentiating neck iodine fixing foci in patients with differentiated thyroid carcinoma (DTC). 62
Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients 62
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease 61
A longitudinal study of bone metabolism in patients with homozygous thalassaemia major 61
The value of semiquantitative FDG-PET parameters in the diagnosis of solitary pulmonary nodules with pre-test intermediate likelihood of malignancy: a single-centre study 61
99mTc-Tetrofosmin (TF) mammoscintigraphy in primary breast cancer (BC) detection: SPECT vs Planar 60
99mTcHMPAO brain SPECT qualitative and quantitative analysis in mild cognitive impairment. 60
Technetium-99m Tetrofosmin SPECT in primary breast cancer detection and axillary lymph node staging 60
Bone Alkaline Phosphatase (BAP) related to Prostate Specific Antigen (PSA) in bone metastasis prostate cancer (PC) patients 60
Qualitative (QL) and 3D Quantitative (QN) analysis of 123I-Ioflupane SPECT in possible Alzheimer’s Disease (AD), Lewy Body Dementia (LBD) and Vascular Dementia (VD) differential diagnosis. 60
99mTc-tetrofosmin planar scintimammography and SPECT in monitoring the response to neoadjuvant hormone or chemotherapy in locally advanced primary breast cancer (LAPBC) 60
A longitudinal study on bone metabolism in HIV patients treated with HAART. 60
A comparative study between two different dedicated breast-specific γ-cameras in the detection of primary breast cancer 60
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors 60
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) 60
131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging 59
The usefulness of high resolution planar scintimammography with dedicated breast camera in the diagnosis of multifocal/multicentric primary breast cancer (BC) 59
123I FP-CIT SPECT in early Parkinson’s disease 59
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 59
The role of 99mTc-tetrofosmin neck pinhole (P)-SPECT in the follow up of patients with differentiated thyroid carcinoma (DTC) 59
Primary Progressive Aphasia (PPA) variants: a diagnostic brain 18F-FDG PET/CT study 59
The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions 58
Role of Ca549 in patients with breast cancer 58
Tc-99m Tetrofosmin (T) SPECT in monitoring the response to treatment in lung cancer (LC) patients 58
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders 58
Cerebral and cerebellar diaschisis following carbamazepine therapy 58
Differentiated thyroid carcinoma (DTC) follow up: a 131I-SPECT/CT study. 58
ERPs and cerebral perfusion correlates in Mild Cognitive Impairment (MCI). 58
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) 57
The follow up of thyroidectomized patients with differentiated thyroid carcinomas (DTC):131 I-SPECT/CT incremental value than planar whole body scan 57
131I SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC). 57
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 57
The usefulness of 99mTc-tetrofosmin SPECT in the detection of primary lung cancer 57
Breast-specific imaging (BSGI) in predicting tumor response to treatment and in assessing residual tumor size following neoadjuvant therapy in locally advanced primary breast cancer. 57
May ERP and SPECT investigations represent early markers of Mild Cognitive Impairment (MCI) 57
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative local staging of primary breast cancer. 57
Artificial neural network classifiers provide cut-off values to differentiate PD and ET by 123I-FP-CIT SPECT. 57
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 57
The usefulness of SPECT/CT and neck pinhole SPECT (P-SPECT) as complementary tools to planar parathyroid scintigraphy in hyperparathyroidism (HPT). 57
SPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases 56
131I-SPECT/CT in differentiated thyroid carcinoma (DTC) 56
Bone mass loss in HIV patients treated with HAART 56
The role of TC-99m Tetrofosmin SPECT in breast cancer diagnosis, axillary lymph node staging and follow up 56
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 56
Assessment of myocardial viability by Thallium-201 reinjection and nitrates 56
99mTc-Tetrofosmin (T) SPECT in thorax metastatic mass (TMM) detection 56
The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences 55
Two 123I-Ioflupane brain SPECT semiquantitative methods to diagnose Parkinson's disease (PS) comparatively evaluated by support vector machine classifier (SVM) 55
99mTcHM-PAO and 123I-Ioflupane brain SPECT usefulness in cognitive and movement associated disorders. 55
Combined 123I-Iofuplane SPECT and 123I-MIBG cardiac scintigraphy use in Parkinson disease(PD) and vascular Parkinsonism(VP) differential diagnosis. 55
Tc-99m-tetrofosmin pinhole-SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging 55
Breast cancer axillary lymph node metastasis detection by a high-resolution dedicated breast camera: a comparative study with SPECT and pinhole SPECT 55
Uremia, trapianto renale e cancro. Ruolo dei marcatori tumorali nella diagnosi e nel monitoraggio. 55
Neuropsychophysiological findings in a case of long-standing overt ventriculomegaly (LOVA) 54
The role of planar scintimammography with high-resolution dedicated breast camera in the diagnosis of primary breast cancer 54
The clinical usefulness of CYFRA 21-1 in non small cell lung cancer (NSCLC) 54
The role of 99mTc-tetrofosmin axillary pinhole-SPET (P-SPET) in non palpable axillary lymph node metastases from breast cancer (BC) 54
The assessment of breast cancer (BC) response to neoadjuvant therapy: a SPECT/CT study. 54
The role of Tc-99m Tetrofosmin (T) scan in the post-operative follow-up of breast cancer patients 54
The role of breast scintigraphy with breast-specific γ-camera (BSGC) and SPECT/CT in the preoperative identification of residual breast tumor and axillary lymph node metastases following neoadjuvant therapy 54
The Effects of Drugs on Verbal Fluency 54
123I-MIBG cardiac scintigraphy in discriminating Parkinson’s disease (PD) from vascular Parkinsonism (VP ) using classification tree( CIT ) classifier together with conventional quantitative analysis. 54
Brain SPECT imaging and Neuropsychological tests in Cognitive Impairments 54
Cerebral blood flow after carbamazepine therapy 54
Usefulness of bladder tumour antigen (BTA) and urinary bladder cancer test (UBC) in transitional cell blood cancer (TCC) diagnosis and follow-up 54
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 54
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 54
The usefulness of Ca549 in breast cancer 53
123I-metaiodobenzylguanidine (123I-MIBG)planar cardiac scintigraphy in neurodegenerative cerebral disorder (NCD) differential diagnosi 53
Thyroid function in Thalassemia Major 53
123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders 53
Totale 6.059
Categoria #
all - tutte 74.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.789 0 0 266 115 330 552 607 54 360 137 356 12
2020/20213.036 336 3 557 20 337 228 344 4 480 467 158 102
2021/20221.479 229 13 19 7 13 17 36 124 126 83 154 658
2022/20234.015 384 198 66 736 427 668 12 504 730 24 179 87
2023/20241.505 252 123 58 59 450 109 6 39 3 24 111 271
2024/2025740 115 136 489 0 0 0 0 0 0 0 0 0
Totale 16.279